Leadership Overview
Precision Medicine Group has 9 executives leading key functions including clinical research, laboratory services, genomics, data science, and commercialization strategy.
Focused on accelerating drug development, Precision Medicine Group delivers specialized life sciences services to pharmaceutical and biotech clients across North America, Europe, and Asia-Pacific to improve patient outcomes.
Focused on accelerating drug development, Precision Medicine Group delivers specialized life sciences services to pharmaceutical and biotech clients across North America, Europe, and Asia-Pacific to improve patient outcomes.
Leadership Roles at Precision Medicine Group
Margaret Keegan - Chief Executive Officer
Margaret Keegan, the Chief Executive Officer at Precision Medicine Group, directs the overarching strategic vision for the global life sciences services organization. Overseeing the integration of clinical research and commercialization platforms, the Chief Executive Officer ensures alignment between laboratory services and market access initiatives. This leadership role involves driving operational excellence across North America, Europe, and Asia-Pacific to support pharmaceutical and biotech clients. By optimizing the drug development lifecycle, Margaret Keegan directly impacts the company's ability to bring innovative therapies to market. Through constant collaboration with the board and senior leadership, the Chief Executive Officer maintains a focus on scaling data science capabilities and genomics research. Ultimately, Keegan secures long-term growth by fostering a culture of scientific rigor and client-centric service delivery across all international business units.
Mark Clein - Co-Founder & Chief Executive Officer
Mark Clein, the Co-Founder & Chief Executive Officer at Precision Medicine Group, architects the foundational business model and long-term growth strategy for the enterprise. Managing the expansion of the Precision for Medicine and Precision AQ platforms, the Co-Founder & Chief Executive Officer drives the company's mission to bridge the gap between early-stage development and commercial success. This leadership role involves identifying new market opportunities and maintaining strong relationships with key pharmaceutical partners. By overseeing the strategic direction of the organization, Mark Clein ensures that the company remains at the forefront of clinical research and medical communications. Through the continuous refinement of service offerings, the Co-Founder & Chief Executive Officer supports the delivery of high-impact data science and laboratory solutions. Ultimately, Clein sustains the company's competitive advantage within the global life sciences sector.
Marcus Brown - Vice President, Chief of Staff To the Chief Executive Officer
Marcus Brown, the Vice President, Chief of Staff To the Chief Executive Officer at Precision Medicine Group, directs the execution of strategic initiatives and facilitates communication across the executive leadership team. Overseeing the operational priorities of the Chief Executive Officer, the Vice President, Chief of Staff To the Chief Executive Officer ensures that corporate goals are translated into actionable tasks for all departments. This leadership role involves coordinating cross-functional projects that span clinical research, laboratory services, and commercialization platforms. By streamlining executive decision-making, Marcus Brown directly impacts the agility and responsiveness of the organization. Through the management of key internal processes, the Vice President, Chief of Staff To the Chief Executive Officer maintains alignment between the company's mission and daily operations. Ultimately, Brown supports the leadership team in driving growth and maintaining excellence across all global business units.
Karl Deonanan - Chief Financial Officer
Karl Deonanan, the Chief Financial Officer at Precision Medicine Group, directs the financial planning, reporting, and capital allocation strategies for the entire organization. Overseeing the fiscal health of the company, the Chief Financial Officer ensures that resources are effectively distributed to support clinical research and commercialization platforms. This leadership role involves managing complex financial operations across international markets to maintain profitability and support sustainable growth. By optimizing the financial structure, Karl Deonanan directly impacts the company's ability to invest in new genomics and data science capabilities. Through rigorous analysis and collaboration with the board, the Chief Financial Officer maintains transparency and accountability in all fiscal matters. Ultimately, Deonanan secures the financial stability required to support pharmaceutical and biotech clients from early-stage development through the final stages of commercialization.
Wendy Shusko - Chief Financial Officer, Precision AQ
Wendy Shusko, the Chief Financial Officer, Precision AQ at Precision Medicine Group, directs the financial strategy specifically for the Precision AQ platform, focusing on market access and medical communications. Overseeing the budget and revenue forecasting for this division, the Chief Financial Officer, Precision AQ ensures that financial performance aligns with the commercialization goals of the company. This leadership role involves managing payer insights and medical communications investments to maximize client value. By optimizing the financial performance of the Precision AQ unit, Wendy Shusko directly impacts the company's ability to provide comprehensive commercialization support. Through close coordination with the broader finance team, the Chief Financial Officer, Precision AQ maintains fiscal discipline while fostering innovation in market access services. Ultimately, Shusko drives the financial success of the commercialization arm within the global life sciences landscape.
Michael Winston - Translational Sciences Chief Operating Officer & Chief Financial Officer
Michael Winston, the Translational Sciences Chief Operating Officer & Chief Financial Officer at Precision Medicine Group, directs the operational and financial performance of the translational sciences division. Overseeing the integration of laboratory services and clinical research, the Translational Sciences Chief Operating Officer & Chief Financial Officer ensures that scientific output meets the highest standards of quality and efficiency. This leadership role involves managing the financial resources dedicated to genomics and data science to support drug development. By optimizing operational workflows, Michael Winston directly impacts the speed and accuracy of clinical trial results for pharmaceutical clients. Through strategic oversight, the Translational Sciences Chief Operating Officer & Chief Financial Officer aligns scientific capabilities with the company's broader commercial objectives. Ultimately, Winston ensures the operational and financial viability of the translational sciences platform within the global market.
Chad Clarke - President
Chad Clarke, the President at Precision Medicine Group, directs the day-to-day operations and business development efforts across the company's diverse service platforms. Overseeing the execution of the corporate strategy, the President ensures that the organization effectively supports pharmaceutical and biotech clients throughout the entire drug development and commercialization process. This leadership role involves driving market expansion and maintaining high standards of service delivery in clinical research, laboratory services, and market access. By optimizing the performance of the various business units, Chad Clarke directly impacts the company's revenue growth and market position. Through constant engagement with the leadership team, the President fosters a culture of innovation and operational excellence. Ultimately, Clarke ensures that the company remains a trusted partner for clients seeking to navigate the complexities of the global life sciences industry.
Othniel Badea - Chief Technology Officer
Othniel Badea, the Chief Technology Officer at Precision Medicine Group, directs the digital infrastructure and data science capabilities that underpin the company's clinical research services. Overseeing the implementation of advanced genomics platforms, the Chief Technology Officer ensures that technological assets remain scalable and secure for global pharmaceutical clients. This leadership role involves integrating complex data sets to provide actionable insights for drug development programs. By optimizing the digital ecosystem, Othniel Badea directly impacts the efficiency of laboratory operations and clinical trial management. Through collaboration with the executive team, the Chief Technology Officer aligns technical innovation with the broader commercialization goals of the organization. Ultimately, Badea drives the digital transformation necessary to maintain the company's position as a leader in precision medicine and data-driven life sciences solutions.
David Winn - Chief Administrative Officer, Clinical Solutions
David Winn, the Chief Administrative Officer, Clinical Solutions at Precision Medicine Group, directs the administrative infrastructure and operational support for the clinical solutions division. Overseeing the logistical and organizational frameworks that enable clinical research, the Chief Administrative Officer, Clinical Solutions ensures that teams have the necessary resources to execute complex drug development programs. This leadership role involves managing the administrative processes that support laboratory services and genomics research across North America and international regions. By optimizing administrative efficiency, David Winn directly impacts the ability of the clinical solutions team to deliver high-quality results to pharmaceutical clients. Through collaboration with other C-suite leaders, the Chief Administrative Officer, Clinical Solutions aligns administrative support with the company's overarching strategic goals. Ultimately, Winn maintains the operational foundation required for successful clinical trial execution and client service delivery.
Explore Leadership Teams in Advertising Networks
ISG (Information Services Group) is a leading global technology research and advisory firm that specializes in helping enterprises navigate digital transformation and optimize their technology investments. The company provides comprehensive consulting services, market intelligence, and strategic guidance to organizations seeking to modernize their IT infrastructure, improve operational efficiency, and leverage emerging technologies. ISG's expertise spans across various domains including cloud computing, cybersecurity, digital workplace solutions, automation, and enterprise software, enabling clients to make informed decisions about technology sourcing, vendor selection, and service provider management. The firm conducts extensive market research and produces authoritative industry reports that benchmark service providers and technology vendors, offering valuable insights into market trends and best practices. ISG serves a diverse client base ranging from large multinational corporations to mid-market enterprises across multiple industries, acting as a trusted advisor throughout the entire technology lifecycle from strategy development to implementation and ongoing optimization. Through their deep industry knowledge and global presence, ISG helps organizations transform their business operations, reduce costs, and achieve sustainable competitive advantages in an increasingly digital marketplace.
Company Leadership MC
AK
Founded in 1974, MGT Consulting partners with government organizations, school districts, higher education institutions, and not-for-profits to help them achieve long-term success. They use subject matter expertise to offer unique insights and advice. MGT Consulting is headquartered in Tampa, Florida.
Company Leadership
RB
MG
SM
Oral Surgery Partners offers expert practice management services tailored for oral surgeons, enabling them to concentrate on their surgical expertise. Their services include marketing, recruitment support, and comprehensive management of administrative tasks such as insurance and billing. By collaborating with OSP, oral surgeons can enhance their practice's effectiveness, increase profits, and improve patient care. The company's mission is to empower oral surgeons to thrive while preserving their autonomy and focusing on what they do best.
Company Leadership
TC
JS
KR
Phoenix Capital is an advisory firm that serves the mortgage banking industry. The firm offers MSR & whole loan trade advisory, marketing strategy, servicing oversight & quality control, MSR financial reporting & advisory, and more. Phoenix Capital was founded in 2001 and is headquartered in Denver, Colorado.
Company Leadership DD
SO
JB
Frequently Asked Questions Regarding Precision Medicine Group Top Executives and Leadership Team
